Imagen de Portada

Confidence distributions for treatment effects in clinical trials: Posteriors without priors

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autor principal:	Ian C. Marschner
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Statistics in Medicine
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Assurance methods for designing a clinical trial with a delayed treatment effect
por: James A. Salsbury, et al.
Publicado: (2024)

Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time‐to‐event endpoints
por: Matthias Kormaksson, et al.
Publicado: (2024)

Comparison of methods that combine multiple randomized trials to estimate heterogeneous treatment effects
por: Carly Lupton Brantner, et al.
Publicado: (2024)

Confidence intervals for odds ratio from multistage randomized phase II trials
por: Shiwei Cao, et al.
Publicado: (2024)

Correction to “Using principal stratification in analysis of clinical trials”
por: Ilya Lipkovich, et al.
Publicado: (2024)

Collaborative inference for treatment effect with distributed data‐sharing management in multicenter studies
por: Mengtong Hu, et al.
Publicado: (2024)

Use of win time for ordered composite endpoints in clinical trials
por: James F. Troendle, et al.
Publicado: (2024)

Correction to “Propensity score weighting for covariate adjustment in randomized clinical trials”
por: Shuxi Zeng, et al.
Publicado: (2024)

REDOMA: Bayesian random‐effects dose‐optimization meta‐analysis using spike‐and‐slab priors
por: Cheng‐Han Yang, et al.
Publicado: (2024)

Group sequential designs for clinical trials when the maximum sample size is uncertain
por: Amin Yarahmadi, et al.
Publicado: (2024)

A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials
por: Yu Du, et al.
Publicado: (2024)

Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs
por: Jonathan C. Moyer, et al.
Publicado: (2024)

Dual‐agent dose‐finding in Phase I clinical trial—An extension of rapid enrollment design
por: Yunfei Wang
Publicado: (2024)

Doubly adaptive biased coin design to improve Bayesian clinical trials with time‐to‐event endpoints
por: Wenhao Cao, et al.
Publicado: (2024)

Adding experimental treatment arms to multi‐arm multi‐stage platform trials in progress
por: Thomas Burnett, et al.
Publicado: (2024)

Integrative deep learning with prior assisted feature selection
por: Feifei Wang, et al.
Publicado: (2024)

A class of computational methods to reduce selection bias when designing Phase 3 clinical trials
por: Tianyu Zhan
Publicado: (2024)

A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart
por: Stephen Schüürhuis, et al.
Publicado: (2024)

Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial
por: Johannes Krisam, et al.
Publicado: (2024)

Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs
por: Luana Boumendil, et al.
Publicado: (2024)

Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two‐by‐two table
por: Edward L. Korn, et al.
Publicado: (2024)

Fractional accumulative calibration‐free odds (f‐aCFO) design for delayed toxicity in phase I clinical trials
por: Jialu Fang, et al.
Publicado: (2024)

Minimum Area Confidence Set Optimality for Simultaneous Confidence Bands for Percentiles With Applications to Drug Shelf‐Life Estimation
por: Lingjiao Wang, et al.
Publicado: (2025)

Likelihood Confidence Intervals for Misspecified Cox Models
por: Yongwu Shao, et al.
Publicado: (2026)

Finding the best subgroup with differential treatment effect with multiple outcomes
por: Beibo Zhao, et al.
Publicado: (2024)

Validation of predicted individual treatment effects in out of sample respondents
por: Alena Kuhlemeier, et al.
Publicado: (2024)

Survival causal rule ensemble method considering the main effect for estimating heterogeneous treatment effects
por: Ke Wan, et al.
Publicado: (2024)

Are the tests overpowered or underpowered? A unified solution to correctly specify type I errors in design of clinical trials for two sample proportions
por: Peiran Liu, et al.
Publicado: (2024)

Determining sample size in a personalized randomized controlled (PRACTical) trial
por: Rebecca M. Turner, et al.
Publicado: (2024)

Confidence sets for a level set in linear regression
por: Fang Wan, et al.
Publicado: (2024)

Confidence Intervals for AUC and pAUC by Empirical Likelihood
por: Yumin Zhao, et al.
Publicado: (2025)

Confidence Set for the Cluster of a Spatial Scan Statistic
por: Junho Lee
Publicado: (2026)

Improved mortality analysis in early‐phase dose‐ranging clinical trials for emergency medical diseases using Bayesian time‐to‐event models with active comparators
por: Xiaosong Shi, et al.
Publicado: (2024)

Comparing two hazard curves when there is a treatment time‐lag effect
por: Xiaoxi Zhang, et al.
Publicado: (2024)

Skewness‐Corrected Confidence Intervals for Predictive Values in Enrichment Studies
por: Dadong Zhang, et al.
Publicado: (2024)

Bayesian Hierarchical Models With Calibrated Mixtures of g‐priors for Assessing Treatment Effect Moderation in Meta‐Analysis
por: Qiao Wang, et al.
Publicado: (2026)

Confidence Intervals and Sample Size for the ICC in Two‐Way ANOVA Models
por: Dipro Mondal, et al.
Publicado: (2025)

Beyond the two‐trials rule
por: Leonhard Held
Publicado: (2024)

Confidence Interval Construction for Causally Generalized Estimates With Target Sample Summary Information
por: Yi Chen, et al.
Publicado: (2026)

Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance
por: David S. Robertson, et al.
Publicado: (2025)